Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT ID: NCT02814682
Last Updated: 2016-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
560 participants
OBSERVATIONAL
2012-12-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will, as secondary objectives:
* elaborate in a standard manner one set of indicators of organization and inner working of a palliative care setting.
* compare according to these indicators, the qualities of 3 types of palliative care: palliative care unit in hospitals, specified identified bed for palliative care patients and non-specified bed.
* explore the relationship between organizational aspects and results in term of burden.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Obstacles and Levers to Interdisciplinary Work in Palliative Care Units
NCT06208644
Cancer End Of Life Evaluation
NCT01545921
Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.
NCT01865396
Perceptions of Health Professionals Confronted With Palliative Situations
NCT03021967
From Active to Palliative Care: Emotional Burden and Self Efficacy in Patients and Caregivers
NCT05796947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with serious progressive illness and in terminal phase (life expectancy \< 3 months): OMS stage is 3 or 4, regardless of etiology.
* Patient informed their diagnosis or not.
* Hospitalized at the moment of inclusion in one of the following care settings: palliative care unit, identified bed or non-identified bed in a care department of short stay.
* No-oppose to participate to the study, by patients, their families or trusted person.
Exclusion Criteria
* Hospitalization in the palliative care setting \< 48 hours.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric GUIRIMAND, MD
Role: STUDY_CHAIR
Maison Médicale Jeanne Garnier
Philippe Aegerter, MD, PhD
Role: STUDY_DIRECTOR
Hôpital Ambroise Paré, AP-HP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maison Médicale Jeanne Garnier
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guirimand F, Martel-Samb P, Guy-Coichard C, Picard S, Devalois B, Copel L, Abel A, Ghadi V; QUALI-PALLI group and Philippe Aegerter. Development and validation of a French questionnaire concerning patients' perspectives of the quality of palliative care: the QUALI-PALLI-Patient. BMC Palliat Care. 2019 Feb 11;18(1):19. doi: 10.1186/s12904-019-0403-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRQ0904
Identifier Type: OTHER
Identifier Source: secondary_id
NI 10052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.